Merrill Jumps Up In Slim Equity Field

O'Connor, Collen Marie
March 2005
Investment Dealers' Digest;3/21/2005, Vol. 71 Issue 11, p7
Trade Publication
Focuses on the financial performance of Merrill Lynch and Co. Inc. for the first quarter of the year 2005 in the U.S. Analysis on the revenue growth of the firm; Prices of the stocks; Amount of funds raised through initial public offerings.


Related Articles

  • The Ugly Truth About IPOs. Schwartz, Nelson D. // Fortune;11/23/1998, Vol. 138 Issue 10, p190 

    Looks at the performance of Merrill Lynch in the initial public offering (IPO) market in the 1990s. Why Merrill Lynch's performance exemplifies the market; Percentage of companies that have gone public and are trading below their offering price; The general poor performance of IPOs backed by...

  • Global reach, once a plus, now hurting Merrill Lynch. Padgett, Tania // American Banker;2/1/1999, Vol. 164 Issue 20, p24 

    Focuses on the market performance of the stock of United States-based Merrill Lynch & Co. Share price as of January 29, 1999; Debate on the company's earnings sustainability; Impact of market volatility overseas.

  • GET LEAN WHEN THE TIMES ARE FAT. Michels, Antony J. // Fortune;5/17/1993, Vol. 127 Issue 10, p97 

    Presents information on cost controlling steps taken by Merrill Lynch & Co. Inc. in 1989. Reasons behind the company's cost getting out of control; Graph indicating the performance of stock price of the company during the period 1989 to 1993; Effect of the new bonus system and fee-based business...

  • Grand Canyon Trims IPO Price. Schachter, Ken // Red Herring;11/19/2008, p6 

    The article reports that the price range of Grand Canyon Education's initial public offering (IPO) has been cut to $12-$14 per share. This reduced the deal size from about $178.5 million to $136.5 million. The 10.5 million-share deal was underwritten by bankers led by Credit Suisse and Merrill...

  • MAP seeks to raise $69M in IPO; Helixis adds partner to 'A' round.  // Medical Device Daily;10/8/2007, Vol. 11 Issue 192, p4 

    The article reports on the initial public offering of MAP Pharmaceuticals. It has priced 5 million shares of common stock at a price of $12 per share. Morgan Stanley & Co. and Merrill Lynch & Co. are joint book-running managers for the offering, and Deutsche Bank Securities is co-lead manager...

  • Merrill Says 2003 Was Record Year.  // American Banker;1/16/2004, Vol. 169 Issue 11, p20 

    States that Merrill Lynch & Co. reported profits last year exceeding the record earned in 2000. Financial data for Merrill; Reason for the earnings record.

  • Bonduelle Deal Incites Buyside Food Fight. Colomer, Nora // Private Placement Letter;05/01/2000, Vol. 18 Issue 18, p1 

    Deals with the reception received by Bonduelle's initial public offering agented by Merrill Lynch. Structure of the offering; Bonduelle's business operations.

  • Interactive Intelligence IPO delayed to mid-August. Pugh, Lori // Indianapolis Business Journal;08/02/99, Vol. 20 Issue 20, p6 

    Reports on the delay of Indianapolis, Indiana-based Interactive Intelligence Inc.'s initial public offering. Amendment of the company's preliminary prospectus; Merrill Lynch Co. Inc. as underwriter for the company; Crowding of regulatory calendar as reason for the delay.

  • Logging on too late to cyber-reality? Winston, Paul D. // Business Insurance;06/07/99, Vol. 33 Issue 23, p45 

    Expresses concern on the proliferation of Internet-related businesses. Weekly launching of initial public offering by Internet-related firms; Reactions from online brokerage ventures on Merrill Lynch & Co.'s announcement to enter the discount online-trading business.


Read the Article


Sign out of this library

Other Topics